Covid-19 Vaccine 30 µg per dose Suppliers & Bulk Manufacturers
Available Forms: Vial for reconstitution (injectable, intramuscular)
Available Strengths: 30 µg per dose
Reference Brands: Comirnaty
Category: Nanoemulsion/Nanoparticles
Comirnaty (Pfizer-BioNTech COVID-19 vaccine) uses mRNA technology to instruct cells to produce spike proteins, triggering an immune response. It provides strong protection against COVID-19, reduces severe illness, and supports herd immunity. Benefits include rapid immune activation and high efficacy in preventing infection and complications.
Product Description:
Comirnaty (Pfizer-BioNTech COVID-19 vaccine) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. FDA approval involved extensive clinical validation, safety monitoring, and efficacy data, while in the EU, CE marking certifies conformity with MDR standards. Both regions require validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial results, and quality management systems. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective COVID-19 vaccines supporting global health efforts and pandemic control.
Covid-19 Vaccine — third party manufacturing & bulk supply
Covid-19 Vaccine 30 µg per dose is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Covid-19 Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Covid-19 Vaccine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Givosiran Infusion
Strength:
2.5 mg/kg IV infusion
Form: Intravenous infusion
Reference Brands: Givlaari
View Details
Patisiran Infusion
Strength:
0.3 mg/mL
Form: Intravenous (IV) infusion
Reference Brands: Onpattro
View DetailsQuick Response Guaranteed | Verified Suppliers
